FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$114M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$101M
2
+$15.4M
3
+$15M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$5.41M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$3.87M

Top Sells

1
+$80.9M
2
+$26.5M
3
+$21.7M
4
PCVX icon
Vaxcyte
PCVX
+$11.4M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$10.2M

Sector Composition

1 Healthcare 98.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$10.6M 1%
3,746,857
27
$10.5M 1%
203,684
28
$10.4M 0.99%
881,173
29
$9.83M 0.93%
1,375,065
+47,400
30
$9.26M 0.87%
1,776,479
31
$5.7M 0.54%
408,329
32
$5.35M 0.5%
202,260
+146,425
33
$3.29M 0.31%
+1,171,627
34
$2.6M 0.25%
845,636
-1,235,371
35
$2.28M 0.22%
585,759
36
$2.18M 0.21%
692,910
37
$1.64M 0.15%
170,000
-2,251,563
38
$1.25M 0.12%
91,603
39
$1.09M 0.1%
739,369
40
$1.05M 0.1%
1,883,244
41
$77K 0.01%
17,026
42
– –
-951,814
43
– –
-603,521
44
– –
-156,000
1
2